Liver Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1096-1104
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1096
Figure 6
Figure 6 Effect of genistein, p38 MAPK inhibitor (SB 202190), and UO126 on the induction of MMP-2 and MMP-9 mRNA expression in HepG2 (A and C) and HepG2 TIMP-1 overexpressing cell clones (B and D). Cells were treated with Genistein 25 µM (2), Genistein 50 µM (3), SB202190 (4), and UO126 (5). mRNA expression of untreated cells (1) were set to 100%. Incubation with DMSO served as control (6).